FOXM1 and stroke disorder: This work primarily advances the understanding of the molecular mechanisms governing exosome-mediated neuroprotection and explicitly frames in vivo validation of the hAECs-Exos/FoxM1 axis as a key next step to move toward potential clinical application in stroke treatment.